img

Global and India Multiparametric In-vitro Cardiotoxicity Testing Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global and India Multiparametric In-vitro Cardiotoxicity Testing Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Multiparametric In-vitro Cardiotoxicity Testing Market
This report focuses on global and India Multiparametric In-vitro Cardiotoxicity Testing market, also covers the segmentation data of other regions in regional level and county level.
The global Multiparametric In-vitro Cardiotoxicity Testing revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Multiparametric In-vitro Cardiotoxicity Testing revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Multiparametric In-vitro Cardiotoxicity Testing include Creative Bioarray, Agilent Technologies, Inc., Hemogenix Inc., Merck KGaA, Molecular Devices, LLC., Miltenyi Biotec, FUJIFILM Cellular Dynamics, Enzo Life Sciences, Inc. and Axol Bioscience Ltd., etc. The global five biggest players hold a share of % in 2023.
Global Multiparametric In-vitro Cardiotoxicity Testing Scope and Market Size
Multiparametric In-vitro Cardiotoxicity Testing market is segmented in regional and country level, by players, by Type of Assay and by Application. Companies, stakeholders, and other participants in the global Multiparametric In-vitro Cardiotoxicity Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type of Assay and by Application for the period 2018-2033.
For India market, this report focuses on the Multiparametric In-vitro Cardiotoxicity Testing market size by players, by Type of Assay and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.



By Company


Creative Bioarray
Agilent Technologies, Inc.
Hemogenix Inc.
Merck KGaA
Molecular Devices, LLC.
Miltenyi Biotec
FUJIFILM Cellular Dynamics
Enzo Life Sciences, Inc.
Axol Bioscience Ltd.
emka TECHNOLOGIES
Eurofins Discovery
Stemina Biomarker Discovery, Inc.
Evotec
Segment by Type of Assay
Calcium Transient Assay
Cardiac Marker Detection
hERG Assay
Multi-ion Channel Assay
Others

Segment by Application


Contract Research Organizations (CROs)
Pharmaceutical and Biotech Companies
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Multiparametric In-vitro Cardiotoxicity Testing definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type of assay, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Multiparametric In-vitro Cardiotoxicity Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Multiparametric In-vitro Cardiotoxicity Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type of assay, by application and by country revenue for each segment.
Chapter 7EMEA by type of assay, by application and by region, revenue for each segment.
Chapter 8China by type of assay, by application revenue for each segment.
Chapter 9APAC (excluding China) by type of assay, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multiparametric In-vitro Cardiotoxicity Testing revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Multiparametric In-vitro Cardiotoxicity Testing Product Introduction
1.2 Global Multiparametric In-vitro Cardiotoxicity Testing Outlook 2018 VS 2023 VS 2033
1.2.1 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size for the Year 2018-2033
1.2.2 India Multiparametric In-vitro Cardiotoxicity Testing Market Size for the Year 2018-2033
1.3 Multiparametric In-vitro Cardiotoxicity Testing Market Size, India VS Global, 2018 VS 2023 VS 2033
1.3.1 The Market Share of India Multiparametric In-vitro Cardiotoxicity Testing in Global, 2018 VS 2023 VS 2033
1.3.2 The Growth Rate of Multiparametric In-vitro Cardiotoxicity Testing Market Size, India VS Global, 2018 VS 2023 VS 2033
1.4 Multiparametric In-vitro Cardiotoxicity Testing Market Dynamics
1.4.1 Multiparametric In-vitro Cardiotoxicity Testing Industry Trends
1.4.2 Multiparametric In-vitro Cardiotoxicity Testing Market Drivers
1.4.3 Multiparametric In-vitro Cardiotoxicity Testing Market Challenges
1.4.4 Multiparametric In-vitro Cardiotoxicity Testing Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Multiparametric In-vitro Cardiotoxicity Testing by Type of Assay
2.1 Multiparametric In-vitro Cardiotoxicity Testing Market Segment by Type of Assay
2.1.1 Calcium Transient Assay
2.1.2 Cardiac Marker Detection
2.1.3 hERG Assay
2.1.4 Multi-ion Channel Assay
2.1.5 Others
2.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018, 2023 & 2033)
2.3 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2033)
2.4 India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018, 2023 & 2033)
2.5 India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2033)
3 Multiparametric In-vitro Cardiotoxicity Testing by Application
3.1 Multiparametric In-vitro Cardiotoxicity Testing Market Segment by Application
3.1.1 Contract Research Organizations (CROs)
3.1.2 Pharmaceutical and Biotech Companies
3.1.3 Others
3.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018, 2023 & 2033)
3.3 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2033)
3.4 India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018, 2023 & 2033)
3.5 India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2033)
4 Global Multiparametric In-vitro Cardiotoxicity Testing Competitor Landscape by Company
4.1 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Company
4.1.1 Global Key Companies of Multiparametric In-vitro Cardiotoxicity Testing, Ranked by Revenue (2023)
4.1.2 Global Multiparametric In-vitro Cardiotoxicity Testing Revenue by Player (2018-2023)
4.2 Global Multiparametric In-vitro Cardiotoxicity Testing Concentration Ratio (CR)
4.2.1 Multiparametric In-vitro Cardiotoxicity Testing Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Multiparametric In-vitro Cardiotoxicity Testing in 2023
4.2.3 Global Multiparametric In-vitro Cardiotoxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Multiparametric In-vitro Cardiotoxicity Testing Head office and Area Served
4.4 Global Key Players of Multiparametric In-vitro Cardiotoxicity Testing, Product and Application
4.5 Global Key Players of Multiparametric In-vitro Cardiotoxicity Testing, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Company
4.7.1 Key Players of Multiparametric In-vitro Cardiotoxicity Testing in India, Ranked by Revenue (2023)
4.7.2 India Multiparametric In-vitro Cardiotoxicity Testing Revenue by Players (2021, 2023 & 2023)
5 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region
5.1 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region: 2018 VS 2023 VS 2033
5.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region (2018-2033)
5.2.1 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region: 2018-2023
5.2.2 Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region (2024-2033)
6 Americas
6.1 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size YoY Growth 2018-2033
6.2 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay
6.2.1 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023)
6.2.2 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033)
6.2.3 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
6.3 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application
6.3.1 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023)
6.3.2 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033)
6.3.3 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
6.4 Americas Multiparametric In-vitro Cardiotoxicity Testing Market Facts & Figures by Country (2018, 2023 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size YoY Growth 2018-2033
7.2 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay
7.2.1 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023)
7.2.2 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033)
7.2.3 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
7.3 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application
7.3.1 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023)
7.3.2 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033)
7.3.3 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
7.4 EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Facts & Figures by Country (2018, 2023 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Multiparametric In-vitro Cardiotoxicity Testing Market Size YoY Growth 2018-2033
8.2 China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay
8.2.1 China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023)
8.2.2 China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033)
8.2.3 China Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
8.3 China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application
8.3.1 China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023)
8.3.2 China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033)
8.3.3 China Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size YoY Growth 2018-2033
9.2 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay
9.2.1 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023)
9.2.2 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033)
9.2.3 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
9.3 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application
9.3.1 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023)
9.3.2 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033)
9.3.3 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
9.4 APAC Multiparametric In-vitro Cardiotoxicity Testing Market Facts & Figures by Country (2018, 2023 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Creative Bioarray
10.1.1 Creative Bioarray Company Details
10.1.2 Creative Bioarray Business Overview
10.1.3 Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.1.4 Creative Bioarray Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.1.5 Creative Bioarray Recent Development
10.2 Agilent Technologies, Inc.
10.2.1 Agilent Technologies, Inc. Company Details
10.2.2 Agilent Technologies, Inc. Business Overview
10.2.3 Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.2.4 Agilent Technologies, Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.2.5 Agilent Technologies, Inc. Recent Development
10.3 Hemogenix Inc.
10.3.1 Hemogenix Inc. Company Details
10.3.2 Hemogenix Inc. Business Overview
10.3.3 Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.3.4 Hemogenix Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.3.5 Hemogenix Inc. Recent Development
10.4 Merck KGaA
10.4.1 Merck KGaA Company Details
10.4.2 Merck KGaA Business Overview
10.4.3 Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.4.4 Merck KGaA Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.4.5 Merck KGaA Recent Development
10.5 Molecular Devices, LLC.
10.5.1 Molecular Devices, LLC. Company Details
10.5.2 Molecular Devices, LLC. Business Overview
10.5.3 Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.5.4 Molecular Devices, LLC. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.5.5 Molecular Devices, LLC. Recent Development
10.6 Miltenyi Biotec
10.6.1 Miltenyi Biotec Company Details
10.6.2 Miltenyi Biotec Business Overview
10.6.3 Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.6.4 Miltenyi Biotec Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.6.5 Miltenyi Biotec Recent Development
10.7 FUJIFILM Cellular Dynamics
10.7.1 FUJIFILM Cellular Dynamics Company Details
10.7.2 FUJIFILM Cellular Dynamics Business Overview
10.7.3 FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.7.4 FUJIFILM Cellular Dynamics Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.7.5 FUJIFILM Cellular Dynamics Recent Development
10.8 Enzo Life Sciences, Inc.
10.8.1 Enzo Life Sciences, Inc. Company Details
10.8.2 Enzo Life Sciences, Inc. Business Overview
10.8.3 Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.8.4 Enzo Life Sciences, Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.8.5 Enzo Life Sciences, Inc. Recent Development
10.9 Axol Bioscience Ltd.
10.9.1 Axol Bioscience Ltd. Company Details
10.9.2 Axol Bioscience Ltd. Business Overview
10.9.3 Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.9.4 Axol Bioscience Ltd. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.9.5 Axol Bioscience Ltd. Recent Development
10.10 emka TECHNOLOGIES
10.10.1 emka TECHNOLOGIES Company Details
10.10.2 emka TECHNOLOGIES Business Overview
10.10.3 emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.10.4 emka TECHNOLOGIES Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.10.5 emka TECHNOLOGIES Recent Development
10.11 Eurofins Discovery
10.11.1 Eurofins Discovery Company Details
10.11.2 Eurofins Discovery Business Overview
10.11.3 Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.11.4 Eurofins Discovery Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.11.5 Eurofins Discovery Recent Development
10.12 Stemina Biomarker Discovery, Inc.
10.12.1 Stemina Biomarker Discovery, Inc. Company Details
10.12.2 Stemina Biomarker Discovery, Inc. Business Overview
10.12.3 Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.12.4 Stemina Biomarker Discovery, Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.12.5 Stemina Biomarker Discovery, Inc. Recent Development
10.13 Evotec
10.13.1 Evotec Company Details
10.13.2 Evotec Business Overview
10.13.3 Evotec Multiparametric In-vitro Cardiotoxicity Testing Introduction
10.13.4 Evotec Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
10.13.5 Evotec Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Multiparametric In-vitro Cardiotoxicity Testing Market Size India VS Global, CAGR (2018 VS 2023 VS 2033)
Table 2. Multiparametric In-vitro Cardiotoxicity Testing Market Trends
Table 3. Multiparametric In-vitro Cardiotoxicity Testing Market Drivers
Table 4. Multiparametric In-vitro Cardiotoxicity Testing Market Challenges
Table 5. Multiparametric In-vitro Cardiotoxicity Testing Market Restraints
Table 6. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay: 2018 VS 2023 VS 2033 (US$ Million)
Table 7. India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay: 2018 VS 2023 VS 2033 (US$ Million)
Table 8. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 9. India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 10. Global Key Companies of Multiparametric In-vitro Cardiotoxicity Testing, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Multiparametric In-vitro Cardiotoxicity Testing Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Multiparametric In-vitro Cardiotoxicity Testing Revenue Share by Player, 2018-2023
Table 13. Global Multiparametric In-vitro Cardiotoxicity Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Multiparametric In-vitro Cardiotoxicity Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiparametric In-vitro Cardiotoxicity Testing as of 2023)
Table 15. Global Key Players of Multiparametric In-vitro Cardiotoxicity Testing, Headquarters and Area Served
Table 16. Global Key Players of Multiparametric In-vitro Cardiotoxicity Testing, Product and Application
Table 17. Global Key Players of Multiparametric In-vitro Cardiotoxicity Testing, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Multiparametric In-vitro Cardiotoxicity Testing in India, Ranked by Revenue (2023) & (US$ Million)
Table 20. India Multiparametric In-vitro Cardiotoxicity Testing Revenue by Players, (US$ Million), 2021, 2023 & 2023
Table 21. India Multiparametric In-vitro Cardiotoxicity Testing Revenue Share by Players, 2021, 2023 & 2023
Table 22. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 23. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023) & (US$ Million)
Table 26. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033) & (US$ Million)
Table 27. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 30. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023) & (US$ Million)
Table 33. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033) & (US$ Million)
Table 34. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023) & (US$ Million)
Table 40. China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033) & (US$ Million)
Table 41. China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2023) & (US$ Million)
Table 45. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2024-2033) & (US$ Million)
Table 46. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 49. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size by Region (2024-2033) & (US$ Million)
Table 51. Creative Bioarray Company Details
Table 52. Creative Bioarray Business Overview
Table 53. Creative Bioarray Multiparametric In-vitro Cardiotoxicity Testing Product
Table 54. Creative Bioarray Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 55. Creative Bioarray Recent Development
Table 56. Agilent Technologies, Inc. Company Details
Table 57. Agilent Technologies, Inc. Business Overview
Table 58. Agilent Technologies, Inc. Multiparametric In-vitro Cardiotoxicity Testing Product
Table 59. Agilent Technologies, Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 60. Agilent Technologies, Inc. Recent Development
Table 61. Hemogenix Inc. Company Details
Table 62. Hemogenix Inc. Business Overview
Table 63. Hemogenix Inc. Multiparametric In-vitro Cardiotoxicity Testing Product
Table 64. Hemogenix Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 65. Hemogenix Inc. Recent Development
Table 66. Merck KGaA Company Details
Table 67. Merck KGaA Business Overview
Table 68. Merck KGaA Multiparametric In-vitro Cardiotoxicity Testing Product
Table 69. Merck KGaA Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 70. Merck KGaA Recent Development
Table 71. Molecular Devices, LLC. Company Details
Table 72. Molecular Devices, LLC. Business Overview
Table 73. Molecular Devices, LLC. Multiparametric In-vitro Cardiotoxicity Testing Product
Table 74. Molecular Devices, LLC. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 75. Molecular Devices, LLC. Recent Development
Table 76. Miltenyi Biotec Company Details
Table 77. Miltenyi Biotec Business Overview
Table 78. Miltenyi Biotec Multiparametric In-vitro Cardiotoxicity Testing Product
Table 79. Miltenyi Biotec Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 80. Miltenyi Biotec Recent Development
Table 81. FUJIFILM Cellular Dynamics Company Details
Table 82. FUJIFILM Cellular Dynamics Business Overview
Table 83. FUJIFILM Cellular Dynamics Multiparametric In-vitro Cardiotoxicity Testing Product
Table 84. FUJIFILM Cellular Dynamics Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 85. FUJIFILM Cellular Dynamics Recent Development
Table 86. Enzo Life Sciences, Inc. Company Details
Table 87. Enzo Life Sciences, Inc. Business Overview
Table 88. Enzo Life Sciences, Inc. Multiparametric In-vitro Cardiotoxicity Testing Product
Table 89. Enzo Life Sciences, Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 90. Enzo Life Sciences, Inc. Recent Development
Table 91. Axol Bioscience Ltd. Company Details
Table 92. Axol Bioscience Ltd. Business Overview
Table 93. Axol Bioscience Ltd. Multiparametric In-vitro Cardiotoxicity Testing Product
Table 94. Axol Bioscience Ltd. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 95. Axol Bioscience Ltd. Recent Development
Table 96. emka TECHNOLOGIES Company Details
Table 97. emka TECHNOLOGIES Business Overview
Table 98. emka TECHNOLOGIES Multiparametric In-vitro Cardiotoxicity Testing Product
Table 99. emka TECHNOLOGIES Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 100. emka TECHNOLOGIES Recent Development
Table 101. Eurofins Discovery Company Details
Table 102. Eurofins Discovery Business Overview
Table 103. Eurofins Discovery Multiparametric In-vitro Cardiotoxicity Testing Product
Table 104. Eurofins Discovery Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 105. Eurofins Discovery Recent Development
Table 106. Stemina Biomarker Discovery, Inc. Company Details
Table 107. Stemina Biomarker Discovery, Inc. Business Overview
Table 108. Stemina Biomarker Discovery, Inc. Multiparametric In-vitro Cardiotoxicity Testing Product
Table 109. Stemina Biomarker Discovery, Inc. Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 110. Stemina Biomarker Discovery, Inc. Recent Development
Table 111. Evotec Company Details
Table 112. Evotec Business Overview
Table 113. Evotec Multiparametric In-vitro Cardiotoxicity Testing Product
Table 114. Evotec Revenue in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023) & (US$ Million)
Table 115. Evotec Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Multiparametric In-vitro Cardiotoxicity Testing Product Picture
Figure 2. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size 2018-2033 (US$ Million)
Figure 4. India Multiparametric In-vitro Cardiotoxicity Testing Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 5. India Multiparametric In-vitro Cardiotoxicity Testing Market Size 2018-2033 (US$ Million)
Figure 6. India Multiparametric In-vitro Cardiotoxicity Testing Market Share in Global 2018-2033
Figure 7. Multiparametric In-vitro Cardiotoxicity Testing Report Years Considered
Figure 8. Product Picture of Calcium Transient Assay
Figure 9. Product Picture of Cardiac Marker Detection
Figure 10. Product Picture of hERG Assay
Figure 11. Product Picture of Multi-ion Channel Assay
Figure 12. Product Picture of Others
Figure 13. Global Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay in 2023 & 2033
Figure 14. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2033) & (US$ Million)
Figure 15. Global Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
Figure 16. India Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay in 2023 & 2033
Figure 17. India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Type of Assay (2018-2033) & (US$ Million)
Figure 18. India Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
Figure 19. Product Picture of Contract Research Organizations (CROs)
Figure 20. Product Picture of Pharmaceutical and Biotech Companies
Figure 21. Product Picture of Others
Figure 22. Global Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application in 2023 & 2033
Figure 23. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2033) & (US$ Million)
Figure 24. Global Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
Figure 25. India Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application in 2023 & 2033
Figure 26. India Multiparametric In-vitro Cardiotoxicity Testing Market Size by Application (2018-2033) & (US$ Million)
Figure 27. India Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
Figure 28. The Top 5 and 10 Largest Companies of Multiparametric In-vitro Cardiotoxicity Testing in the World: Market Share by Multiparametric In-vitro Cardiotoxicity Testing Revenue in 2023
Figure 29. Global Multiparametric In-vitro Cardiotoxicity Testing Market Size Market Share by Region: 2018 VS 2023 VS 2033
Figure 30. Global Multiparametric In-vitro Cardiotoxicity Testing Market Share by Region (2018-2033)
Figure 31. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 32. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
Figure 33. Americas Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
Figure 34. United States Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Canada Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Mexico Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. Brazil Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 38. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 39. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
Figure 40. EMEA Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
Figure 41. Europe Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Middle East Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. Africa Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 44. China Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. China Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
Figure 46. China Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
Figure 47. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 48. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Share by Type of Assay (2018-2033)
Figure 49. APAC Multiparametric In-vitro Cardiotoxicity Testing Market Share by Application (2018-2033)
Figure 50. Japan Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. South Korea Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. China Taiwan Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Southeast Asia Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. India Multiparametric In-vitro Cardiotoxicity Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 55. Creative Bioarray Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 56. Agilent Technologies, Inc. Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 57. Hemogenix Inc. Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 58. Merck KGaA Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 59. Molecular Devices, LLC. Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 60. Miltenyi Biotec Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 61. FUJIFILM Cellular Dynamics Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 62. Enzo Life Sciences, Inc. Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 63. Axol Bioscience Ltd. Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 64. emka TECHNOLOGIES Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 65. Eurofins Discovery Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 66. Stemina Biomarker Discovery, Inc. Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 67. Evotec Revenue Growth Rate in Multiparametric In-vitro Cardiotoxicity Testing Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries